In the clinical trial, upon catheter removal, there were decreases noted in catheter colonization and skin colonization rates. 3M announced that the Food and Drug Administration (FDA) has approved an ...

3.2 The company identified 5 studies that met their inclusion criteria. There were 3 studies (Maryniak et al. 2009; Olson et al. 2008 and Rupp et al. 2008) that reported nursing satisfaction scores on ...

3M Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M). 3M’s Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing decreases catheter-related bloodstream infections and vascular ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Every IV catheter poses potential for serious and costly complications, including those occurring from commonly used peripheral intravenous (PIV) catheters. According ...

Dubai, UAE, 29 October 2009 – 3M Health Care, a division of 3M, the innovative technology company that produces thousands of products for dozens of diverse industries, recently launched the first ...

The company proposed that using the 3M Tegaderm CHG IV securement dressing (Tegaderm CHG) would not result in changes to the current care pathway or need additional resources. The External Assessment ...